marijuana stocks

ENDEXX Corp. (EDXC)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 35   –   –   –  
Cost of Revenue
Gross Profit 35   –   –   –  
Operating Expenses
Research Development 50 64 2 0
Selling General and Administrative 252 178 99 64
Non Recurring
Others 0 0 0 0
Total Operating Expenses
Operating Income or Loss (268) (243) (101) (65)
Income from Continuing Operations
Total Other Income/Expenses Net 0 36 0 232
Earnings Before Interest And Taxes (267) (207) (333) 167
Interest Expense
Income Before Tax (267) (207) (333) 167
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (267) (207) (333) 399
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (267) (207) (101) 167  
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (267) (207) (101) 167

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc.(TBPMF) Obtains Health Canada Approval for Renewal of its Veterinary Clinical Study

Tetra Bio-Pharma Obtains Health Canada Approval for Renewal of its Veterinary Clinical…

Cresco Labs Inc. (CRLBF) Announces First Quarter 2021 Financial Results Under U.S. GAAP

Cresco Labs Announces First Quarter 2021 Financial Results Under U.S. GAAP  …

Nabis Holdings (NABIF) (NAB) Announces Flagship Investment Into Limited License State Arizona – Vertically Integrated Assets Including Cultivation, Production and Retail Dispensary

VANCOUVER, British Columbia, Jan. 29, 2019 (GLOBE NEWSWIRE) — Nabis Holdings (CSE:NAB;…

$GWPH Lead Plaintiff Deadline in a Newly Filed Class Action

Hagens Berman Reminds GW Pharmaceuticals (NASDAQ:GWPH) Investors of March 21, 2016, Lead…